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Abstract
© 2018 Newlands Press. The review provides an overview of the mesoporous inorganic particles
employed as drug delivery systems for controlled and sustained release of drugs. We have
classified promising nanomaterials for drug delivery on the basis of their natural or synthetic
origin.  Nanoclays  are  available  in  different  morphologies  (nanotubes,  nanoplates  and
nanofibers) and they are typically available at low cost from natural resources. The surface
chemistry of nanoclays is versatile for targeted modifications to control loading and release
properties.  Synthetic nanomaterials  (imogolite,  laponite and mesoporous silica)  present the
advantages  of  well-established  purity  and  availability  with  size  features  that  are  finely
controlled. Both nanoclays and inorganic synthetic nanoparticles can be functionalized forming
organic/inorganic architectures with stimuli-responsive features.
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